REVISTA CHILENA DE ENFERMEDADES RESPIRATORIAS

25 / 110

175
Correspondencia a:
Dra. María Paz Corvalán B.
Sociedad Chilena de Enfermedades Respiratorias
Santa Magdalena 75, Oficina 701
Providencia
Santiago, Chile
Email:
8.- Instituto Nacional del Cáncer USA. Smokefreeespañol.
[septiembre 2017]; Disponible en: https://espanol.
smokefree.gov/.
9.- Guyatt G, Oxman AD, Akl EA, Kunz R,
Vist G, Brozek J, et al. GRADE guidelines: 1.
Introduction-GRADE evidence profiles and summary
of findings tables. J Clin Epidemiol. 2011; 64: 383-94.
Epub 2011/01/05.
10.- Balshem H, Helfand M, Schunemann HJ,
Oxman AD, Kunz R, Brozek J, et al. GRADE
guidelines: 3. Rating the quality of evidence. J Clin
Epidemiol. 2011; 64: 401-6. Epub 2011/01/07.
11.- Higgins DA. Assessing the risk of bias in included
studies. Cochrane handbook for systematic reviews
of interventions 5.0.1. Chichester, UK: John Wiley &
Sons; 2008.
12.- Stead LF, Buitrago D, Preciado N, San-
chez G, Hartmann-Boyce J, Lancaster T.
Physician advice for smoking cessation. The Cochrane
database of systematic reviews. 2013:CD000165. Epub
2013/06/04.
13.- Virtanen SE, Zeebari Z, Rohyo I, Galan-
ti MR. Evaluation of a brief counseling for tobacco
cessation in dental clinics among Swedish smokers and
snus users. A cluster randomized controlled trial (the
FRITT study). Prev Med [Internet]. 2015; 70:[26-32
pp.]. Disponible en:
14.- McRobbie H, Bullen C, Glover M, Whit-
taker R, Wallace-Bell M, Fraser T. New
Zealand smoking cessation guidelines. N Z Med J.
2008; 121: 57-70.
15.- Guías Clínicas de Tratamiento de Personas con Depre-
sión del MINSAL, 2006.
16.- Anthenelli RM, Benowitz NL, West R,
St Aubin L, McRae T, Lawrence D, et al.
Neuropsychiatric safety and efficacy of varenicline,
bupropion, and nicotine patch in smokers with and with-
out psychiatric disorders (EAGLES): a double-blind,
randomised, placebo-controlled clinical trial. Lancet.
2016; 387(10037): 2507-20.
17.- Whittaker R, McRobbie H, Bullen C,
Rodgers A, Gu Y. Mobile phone-based interven-
tions for smoking cessation. The Cochrane database
of systematic reviews. 2016;4:CD006611. Epub
2016/04/12.
18.- Ruiz M. El uso de las nuevas tecnologías en el tra-
tamiento del tabaquismo. In: Editorial Aula Médica,
editor. Tratado de tabaquismo. Madrid, España 2011. p.
387-94.
19.- Subsecretaría de telecomunicaciones. Informe Trimes-
tral del Sector Telecomunicaciones - Primer Trimestre
2017. [31 agosto 2017]; Disponible en:
20.- Muñoz RF, Aguilera A, Schueller SM,
Leykin Y, Pérez-Stable EJ. From online
randomized controlled trials to participant preference
studies: morphing the San Francisco Stop Smoking site
into a worldwide smoking cessation resource. Journal
of medical Internet research. 2012; 14: e64. Epub
2012/06/29.
21.- Stead LF, Perera R, Bullen C, Mant
D, Hartmann-Boyce J, Cahill K, et al.
Nicotine replacement therapy for smoking cessa-
tion. The Cochrane database of systematic reviews.
2012;11:CD000146. Epub 2012/11/16.
22.- Behrakis P. Tobacco Cessation Guidelines for high
risk populations The Health Programme of the European
Union 2017.
23.- Milton M MC, Yee S, Backinger C, Ma-
larcher A, Husten C. Youth Tobacco Cessation:
A Guide for Making Informed Decisions. Atlanta: U.S.:
Centers for Disease Control and Prevention, 2004.
24.- Latimer AE, Krishnan-Sarin S, Cavallo
DA, Duhig A, Salovey P, O’Malley SA. Tar-
geted Smoking Cessation Messages for Adolescents. J
Adolesc Health. 50: 47-53.
25.- Zwar N RR, Borland R, Peters M, Litt J,
Bell J. Supporting Smoking Cessation:a Guide for
Health Professionals. Melbourne: The Royal Australian
College of General Practitioners, 2011 (updated 2014).
26.- Ministry of Health. Recommendations of the New Zea-
land Guidelines for Helping People to Stop Smoking.
New Zealand: 2014.
27.- National Institute for Healthcare Excellence (NICE).
Smoking: stopping in pregnancy and after childbirth.
2010.
28.- Hughes JR, Stead LF, Hartmann-Boyce
J, Cahill K, Lancaster T. Antidepressants
for smoking cessation. Cochrane Database Syst Rev.
2014;1:CD000031.
29.- Cahill K, Lindson-Hawley N, Thomas KH,
Fanshawe TR, Lancaster T. Nicotine receptor
partial agonists for smoking cessation. The Cochrane
database of systematic reviews. 2016:CD006103. Epub
2016/05/10.
Guías de Práctica Clínica para el Tratamiento del Tabaquismo
Rev Chil Enferm Respir 2017; 33: 167-175